S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Cliff Asness’s ELV Holdings & Trades

First Buy
Q4 2014
Duration Held
45 Quarters
Largest Add
Q4 2014
+1.98 M Shares
Current Position
621,357 Shares
$217.82 M Value

Cliff Asness's ELV Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 621,357 shares of Elevance Health, Inc. (ELV) worth $217.82 M, representing 0.11% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 45 quarters.

Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 547,950 shares. Largest reduction occurred in Q1 2016, reducing 1.03 M shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Elevance Health (ELV) Holding Value Over Time

Track share changes against reported price movement

Quarterly Elevance Health (ELV) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -179,911 Reduce 22.45% 621,357 $350.55
Q3 2025 +547,950 Add 216.31% 801,268 $322.85
Q2 2025 -389,854 Reduce 60.61% 253,318 $383.31
Q1 2025 +224,536 Add 53.64% 643,172 $434.96
Q4 2024 +68,392 Add 19.53% 418,636 $368.90
Q3 2024 +95,681 Add 37.59% 350,244 $516.41
Q2 2024 -36,546 Reduce 12.55% 254,563 $533.60
Q1 2024 -1,820 Reduce 0.62% 291,109 $518.54
Q4 2023 -3,854 Reduce 1.30% 292,929 $469.29
Q3 2023 +57,138 Add 23.84% 296,783 $435.42
Q2 2023 +19,101 Add 8.66% 239,645 $438.88
Q1 2023 -65,888 Reduce 23.00% 220,544 $459.81
Q4 2022 -19,998 Reduce 6.53% 286,432 $510.77
Q3 2022 +1,765 Add 0.58% 306,430 $454.24
Q2 2022 -154,157 Reduce 33.60% 304,665 $482.58
Q1 2022 -56,050 Reduce 10.89% 458,822 $491.22
Q4 2021 -331,133 Reduce 39.14% 514,872 $463.54
Q3 2021 +135,267 Add 19.03% 846,005 $372.80
Q2 2021 -32,804 Reduce 4.41% 710,738 $380.61
Q1 2021 -31,918 Reduce 4.12% 743,542 $358.95
Q4 2020 -372,738 Reduce 32.46% 775,460 $315.38
Q3 2020 +136,285 Add 13.47% 1.15 M $266.68
Q2 2020 -56,874 Reduce 5.32% 1.01 M $257.09
Q1 2020 -175,743 Reduce 14.12% 1.07 M $227.04
Q4 2019 -6,357 Reduce 0.51% 1.24 M $302.03
Q3 2019 -878,239 Reduce 41.25% 1.25 M $237.99
Q2 2019 -483,961 Reduce 18.52% 2.13 M $277.74
Q1 2019 -349,974 Reduce 11.81% 2.61 M $283.37
Q4 2018 +435,461 Add 17.23% 2.96 M $262.63
Q3 2018 -376,365 Reduce 12.96% 2.53 M $274.05
Q2 2018 -224,084 Reduce 7.16% 2.9 M $238.67
Q1 2018 -327,075 Reduce 9.47% 3.13 M $220.29
Q4 2017 +249,472 Add 7.78% 3.46 M $225.01
Q3 2017 +137,122 Add 4.47% 3.21 M $189.88
Q2 2017 +146 Add 0.00% 3.07 M $188.13
Q1 2017 +315,756 Add 11.47% 3.07 M $165.38
Q4 2016 +118,255 Add 4.49% 2.75 M $143.77
Q3 2016 +445,988 Add 20.38% 2.63 M $125.31
Q2 2016 +251,018 Add 12.96% 2.19 M $131.34
Q1 2016 -1.03 M Reduce 34.61% 1.94 M $138.99
Q4 2015 +473,066 Add 19.00% 2.96 M $139.44
Q3 2015 +179,482 Add 7.77% 2.49 M $140.00
Q2 2015 +338,964 Add 17.20% 2.31 M $164.14
Q1 2015 -5,238 Reduce 0.27% 1.97 M $154.41
Q4 2014 +1.98 M New Buy 1.98 M $125.67

Cliff Asness's Elevance Health Investment FAQs

Cliff Asness first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 1,976,399 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Elevance Health, Inc. (ELV) for 45 quarters since Q4 2014.

Cliff Asness's largest addition to Elevance Health, Inc. (ELV) was in Q4 2014, adding 1,976,399 shares worth $248.37 M.

According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 621,357 shares of Elevance Health, Inc. (ELV), valued at approximately $217.82 M.

As of the Q4 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.11% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Elevance Health, Inc. (ELV) was 3,455,124 shares, as reported at the end of Q4 2017.